MRI offers a unique opportunity for theranostic agent development. By engineering both polymer and peptide materials, we have scope to successfully target, image and treat a range of biological conditions. Here we successfully demonstrate the use of targeted and triggered nanoparticles, encapsulating imaging and chemotherapeutic agents, as theranostics for MRI.
This abstract and the presentation materials are available to members only; a login is required.